首頁資訊 Welldoc擴(kuò)展慢性病數(shù)字健康平臺(tái)，將體重管理納入其中

Welldoc擴(kuò)展慢性病數(shù)字健康平臺(tái)，將體重管理納入其中

來源：泰然健康網(wǎng) 時(shí)間：2024年12月11日 07:35

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc?, a digital health leader revolutionizing chronic care, today announced the expansion of its platform to support weight management. Welldoc’s comprehensive chronic care platform now provides multi-condition support across prediabetes, diabetes, hypertension, heart failure and weight management, along with integrated mental wellbeing and sleep apnea support.

哥倫比亞醫(yī)學(xué)博士-（商業(yè)線）-Welldoc?，一位徹底改變慢性病護(hù)理的數(shù)字健康領(lǐng)導(dǎo)者，今天宣布擴(kuò)大其平臺(tái)以支持體重管理。Welldoc的綜合慢性護(hù)理平臺(tái)現(xiàn)在為前驅(qū)糖尿病，糖尿病，高血壓，心力衰竭和體重管理提供多種條件支持，同時(shí)提供綜合心理健康和睡眠呼吸暫停支持。

Welldoc’s weight management solution is currently available to all customers and will be launching in early 2024 with two of the leading health care companies in the U.S..

Welldoc的體重管理解決方案目前可供所有客戶使用，并將于2024年初與美國兩家領(lǐng)先的醫(yī)療保健公司合作推出。。

Nearly two-thirds of U.S. adults are overweight or obese, which increases their risk of developing chronic comorbid conditions like type 2 diabetes, hypertension, heart failure, and sleep apnea. As part of Welldoc's total health approach to chronic care, AI-driven, personalized digital coaching is available 24/7 to help individuals navigate weight management whether they are just beginning their weight management journey with lifestyle changes or are prescribed a GLP-1 medication.

近三分之二的美國成年人超重或肥胖，這增加了患2型糖尿病，高血壓，心力衰竭和睡眠呼吸暫停等慢性合并癥的風(fēng)險(xiǎn)。作為Welldoc慢性護(hù)理全面健康方法的一部分，AI驅(qū)動(dòng)的個(gè)性化數(shù)字輔導(dǎo)全天候提供，以幫助個(gè)人進(jìn)行體重管理，無論他們剛剛開始改變生活方式的體重管理旅程還是開了GLP-1藥物。

Welldoc enables individuals to understand and connect with their health data in a meaningful way, making the achievement of weight and overall health goals more attainable. Welldoc also provides clinical escalations and decision support for the care team when needed..

Welldoc使個(gè)人能夠以有意義的方式理解并與他們的健康數(shù)據(jù)聯(lián)系起來，從而更容易實(shí)現(xiàn)體重和整體健康目標(biāo)。Welldoc還在需要時(shí)為護(hù)理團(tuán)隊(duì)提供臨床升級(jí)和決策支持。。

“Weight management is a natural extension of Welldoc’s award-winning chronic care platform which has offered best-in-class behavioral support related to nutrition and activity for years. Welldoc is now addressing the evolving needs of our users with an evidence-based weight management program that seamlessly integrates into existing care plans,” said Catherine Brown, Vice President, Clinical Services at Welldoc.

“體重管理是Welldoc獲獎(jiǎng)的慢性護(hù)理平臺(tái)的自然延伸，該平臺(tái)多年來一直提供與營養(yǎng)和活動(dòng)相關(guān)的一流行為支持。Welldoc現(xiàn)在正在通過基于證據(jù)的體重管理解決我們用戶不斷變化的需求。無縫整合到現(xiàn)有護(hù)理計(jì)劃中，“副總裁凱瑟琳·布朗說，Welldoc的臨床服務(wù)。

“We’re thrilled to be launching our weight management program in partnership with two industry-leading health care companies in early 2024, and are confident that together, we can help drive sustainable behavior change and promote better health outcomes through one comprehensive platform.”.

“我們很高興于2024年初與兩家行業(yè)領(lǐng)先的醫(yī)療保健公司合作推出我們的體重管理計(jì)劃，并相信，我們可以通過一個(gè)綜合平臺(tái)共同幫助推動(dòng)可持續(xù)的行為改變并促進(jìn)更好的健康結(jié)果?！薄?/p>

Welldoc partners with pharmacy benefit managers (PBMs), health plans, health systems, and employers with the goal of extending care, improving health, and reducing costs. While many solutions are emerging solely focused on obesity and the prescription of GLP-1 medications, Welldoc employs a more inclusive approach beyond that of a prescription, providing the holistic guidance required to help individuals navigate their day-to-day nutrition, activity, data, and trends over time.

Welldoc與藥房福利經(jīng)理（PBM），健康計(jì)劃，衛(wèi)生系統(tǒng)和雇主合作，旨在擴(kuò)大護(hù)理范圍，改善健康狀況并降低成本。雖然許多解決方案僅關(guān)注肥胖和GLP-1藥物的處方，但Welldoc采用了比處方更具包容性的方法，提供了幫助個(gè)人導(dǎo)航日常營養(yǎng)，活動(dòng)所需的整體指導(dǎo)，數(shù)據(jù)和隨時(shí)間變化的趨勢(shì)。

In addition, Welldoc has extensive expertise in the use of continuous glucose monitoring (CGM) data to support behavior changes and improve clinical outcomes and engagement. As both CGM and GLP-1 use expands, Welldoc is uniquely poised to drive outcomes and adherence for both interventions..

此外，Welldoc在使用連續(xù)血糖監(jiān)測(cè)（CGM）數(shù)據(jù)支持行為改變和改善臨床結(jié)果和參與方面擁有廣泛的專業(yè)知識(shí)。隨著CGM和GLP-1使用范圍的擴(kuò)大，Welldoc在推動(dòng)兩種干預(yù)措施的結(jié)果和依從性方面具有獨(dú)特的優(yōu)勢(shì)。。

Welldoc?, a digital health leader revolutionizing chronic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with chronic conditions, enabling improved health and outcomes. Welldoc’s comprehensive chronic care platform provides multi-condition support across prediabetes, diabetes, hypertension, heart failure, weight management, and mental wellbeing.

Welldoc?是徹底改變慢性病護(hù)理的數(shù)字健康領(lǐng)導(dǎo)者，它將個(gè)性化，實(shí)時(shí)和可行的見解融入慢性病患者的日常生活中，從而改善健康和結(jié)果。Welldoc的綜合慢性護(hù)理平臺(tái)為前驅(qū)糖尿病，糖尿病，高血壓，心力衰竭，體重管理和心理健康提供多種條件支持。

Welldoc’s flagship product, BlueStar?, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.

Welldoc的旗艦產(chǎn)品BlueStar?是FDA批準(zhǔn)的數(shù)字健康解決方案，通過使他們能夠自我管理護(hù)理，同時(shí)加強(qiáng)與醫(yī)療團(tuán)隊(duì)的聯(lián)系，指導(dǎo)個(gè)人完成復(fù)雜的糖尿病生活歷程。Welldoc與健康計(jì)劃，衛(wèi)生系統(tǒng)和雇主合作，旨在擴(kuò)大護(hù)理范圍，改善健康狀況并降低成本。

Welldoc continues to be recognized for our leadership, innovation and partnership across the healthcare industry. This year, Welldoc was named the “Best Overall Digital Health Company” by MedTech Breakthrough, and also received the Innovation and AI Excellence Awards from Business Intelligence Group.

Welldoc繼續(xù)得到我們?cè)谡麄€(gè)醫(yī)療行業(yè)的領(lǐng)導(dǎo)，創(chuàng)新和伙伴關(guān)系的認(rèn)可。今年，Welldoc被MedTech突破評(píng)為“最佳整體數(shù)字健康公司”，并獲得了商業(yè)智能集團(tuán)的創(chuàng)新和AI卓越獎(jiǎng)。

In addition to achieving 11 510(k) clearances for its digital health platform designed to support diabetes health, Welldoc has also built an IP portfolio of 41 patents for its advanced AI and first-in-class tech and currently has more than 75 clinical publications. Among Welldoc’s extensive library of clinical research, Welldoc has 17 publications focused on understanding the value of combining CGM with artificial intelligence (AI) powered digital health solutions.

除了為其旨在支持糖尿病健康的數(shù)字健康平臺(tái)實(shí)現(xiàn)11 510（k）許可之外，Welldoc還為其先進(jìn)的AI和一流技術(shù)建立了41項(xiàng)專利的IP組合，目前擁有超過75項(xiàng)臨床出版物。在Welldoc廣泛的臨床研究圖書館中，Welldoc有17篇出版物專注于理解將CGM與人工智能（AI）支持的數(shù)字健康解決方案相結(jié)合的價(jià)值。

For more information, visit www.welldoc.com. Follow us on LinkedIn and Twitter..

欲了解更多信息，請(qǐng)?jiān)L問www.welldoc.com。在LinkedIn和Twitter上關(guān)注我們。。

網(wǎng)址: Welldoc擴(kuò)展慢性病數(shù)字健康平臺(tái)，將體重管理納入其中 http://www.u1s5d6.cn/newsview436255.html